Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

KERNEIS

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
European Heart Journal|May 22, 2025
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trialNiki Procopi, Michel Zeitouni, Mathieu Kerneis, et al.
Journal of the American College of Cardiology|July 21, 2022
Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in AdultsPetra Barhoum, Marc Pineton de Chambrun, Karim Dorgham, et al.
Annals of Intensive Care|March 24, 2025
Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infectionPaul Quentric, Jean-Luc Charuel, Quentin Moyon, et al.
Chest|November 28, 2020
Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock TrialMichel Zeitouni, Ibrahim Akin, Steffen Desch, et al.
Journal of Autoimmunity|September 20, 2022
Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patientsLévi-Dan Azoulay, Marc Pineton de Chambrun, Romaric Larcher, et al.
Expert Review of Cardiovascular Therapy|October 9, 2018
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolismTarek Nafee, C Michael Gibson, Megan K Yee, et al.
BMJ (Clinical Research Ed.)|May 16, 2020
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care dataMatthieu Mahévas, Viet-Thi Tran, Mathilde Roumier, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 23, 2026
Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysisArianna Morena, Federico Giacobbe, Lorenzo Candido-Todesco, et al.
Archives of Cardiovascular Diseases|April 30, 2021
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in FranceGuillaume Bonnet, Vassili Panagides, Mathieu Becker, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
European Heart Journal|May 22, 2025
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trialNiki Procopi, Michel Zeitouni, Mathieu Kerneis, et al.
Journal of the American College of Cardiology|July 21, 2022
Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in AdultsPetra Barhoum, Marc Pineton de Chambrun, Karim Dorgham, et al.
Annals of Intensive Care|March 24, 2025
Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infectionPaul Quentric, Jean-Luc Charuel, Quentin Moyon, et al.
Chest|November 28, 2020
Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock TrialMichel Zeitouni, Ibrahim Akin, Steffen Desch, et al.
Journal of Autoimmunity|September 20, 2022
Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patientsLévi-Dan Azoulay, Marc Pineton de Chambrun, Romaric Larcher, et al.
Expert Review of Cardiovascular Therapy|October 9, 2018
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolismTarek Nafee, C Michael Gibson, Megan K Yee, et al.
BMJ (Clinical Research Ed.)|May 16, 2020
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care dataMatthieu Mahévas, Viet-Thi Tran, Mathilde Roumier, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 23, 2026
Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysisArianna Morena, Federico Giacobbe, Lorenzo Candido-Todesco, et al.
Archives of Cardiovascular Diseases|April 30, 2021
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in FranceGuillaume Bonnet, Vassili Panagides, Mathieu Becker, et al.
Pageof 21